APPLIED DNA S. NEW DL-001APPLIED DNA S. NEW DL-001APPLIED DNA S. NEW DL-001

APPLIED DNA S. NEW DL-001

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.00 M‬EUR
−9.9572EUR
‪−9.41 M‬EUR
‪12.65 M‬EUR
‪756.77 K‬
Beta (1Y)
0.72

About Applied DNA Sciences, Inc.

CEO
James A. Hayward
Website
Headquarters
Stony Brook
Employees (FY)
55
Founded
1983
FIGI
BBG000HTKNB2
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange APPLIED DNA S. NEW DL-001 stocks are traded under the ticker UDJ.
APPLIED DNA S. NEW DL-001 is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
UDJ earnings for the last quarter are −1.63 EUR per share, whereas the estimation was −5.62 EUR resulting in a 70.97% surprise. The estimated earnings for the next quarter are −4.17 EUR per share. See more details about APPLIED DNA S. NEW DL-001 earnings.
APPLIED DNA S. NEW DL-001 revenue for the last quarter amounts to ‪807.40 K‬ EUR despite the estimated figure of ‪703.06 K‬ EUR. In the next quarter revenue is expected to reach ‪881.37 K‬ EUR.
Yes, you can track APPLIED DNA S. NEW DL-001 financials in yearly and quarterly reports right on TradingView.
UDJ net income for the last quarter is ‪−1.00 M‬ EUR, while the quarter before that showed ‪−3.40 M‬ EUR of net income which accounts for 70.54% change. Track more APPLIED DNA S. NEW DL-001 financial stats to get the full picture.
No, UDJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UDJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APPLIED DNA S. NEW DL-001 stock right from TradingView charts — choose your broker and connect to your account.
UDJ reached its all-time high on May 3, 2024 with the price of 4.6600 EUR, and its all-time low was 0.0010 EUR and was reached on Mar 4, 2011. View more price dynamics on UDJ chart.
See other stocks reaching their highest and lowest prices.
As of May 10, 2024, the company has 55.00 employees. See our rating of the largest employees — is APPLIED DNA S. NEW DL-001 on this list?
We've gathered analysts' opinions on APPLIED DNA S. NEW DL-001 future price: according to them, UDJ price has a max estimate of 56.08 EUR and a min estimate of 28.04 EUR. Watch UDJ chart and read a more detailed APPLIED DNA S. NEW DL-001 stock forecast: see what analysts think of APPLIED DNA S. NEW DL-001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APPLIED DNA S. NEW DL-001 EBITDA is ‪−11.05 M‬ EUR, and current EBITDA margin is −71.75%. See more stats in APPLIED DNA S. NEW DL-001 financial statements.